RE:Pandora ! Job Security future Patent searches ! TLT deck !Oden6570 wrote: Intellectual Property 42 issued patents for its PDC technology in the United States, Canada and internationally ,
23 patents pending Presentation-2022.pdf (theralase.com)
Oden6570...In the link that you provided, page 6&7 are very interesting.
If a Big Pharma does sign a JV(Joint Venture) with TLT, the Big Pharma first goal will be to evaluate the full potential $value of TLT, ACT (Anti-Cancer-Therapy).
In Oden6570 link page 7...
(QALY) = Equate to one year in perfect health.
The average cost of Bladder cancer treatment per QALY is on average $USD100.000 per year.
Big Pharma potential...
Page 6...
US.Can.Europe...
- 243,000 new patients diagnosed with Bladder Cancer each year (US,Can,Europe).
-170,000 patients treated each year with BCG.
-51,000/170,000 patients each year become BCG-Unresponsive(30%/170,000).
Page 7... Big Pharma potential...
-Once TLT ACT will be approved, these 51,000 patients will be eligible for TLT cancer treatment.
-51,000 patients X $USD100,000= $USD 5 billion each year.
-This $5 billion is just for US,Can&Europe(and only for BCG-Unresponsive Patients).
Now let's see what potential $revenue a Big Pharma with worldwide reach, could achieve with TLT Bladder cancer treatment.
https://cancer.net/cancer-types/bladder-cancer/statistics -573,278 new patients diagnosed with Bladder Cancer each year (Worldwide).
-573,278X 70%=400,000 patients per year treated with BCG.
-400,000X30%=120,000 patients per year become BCG-Unresponsive.
-120,000 BCG-Unresponsive patients per year eligible for TLT treatment(Worldwide).
-120,000 patientsX USD$100,000=USD$ 12 billion per year.
Let's get something straight, a Big Pharma will never ever get USD$12 billion in revenue per year from TLT cancer treatment, but still the potential is there and will certainly influence the Big Pharma decision making in a JV with TLT(could spark a big pharma war).
If Theralase does sign a JV with a Big Pharma that has Worldwide reach, the money deal $value could be bigger than expected.